Both the semaglutide and tirzepatide shortages that made compounding legally available were declared resolved in 2024 and 2025, the compounding wind-down deadlines have passed, and in April 2026 the FDA proposed closing the remaining legal pathway entirely
Kratom side effects at low doses When used in lower doses, there are some common side effects that can occur with kratom use
Emerging clinical evidence supports these findings, although the underlying mechanisms remain to be fully elucidated [18,62]
For state Medicaid coverage, the price reductions will occur through supplemental rebate agreements between the state and manufacturers
No safety concern was reported (Fig 1B, left panel)
Very considerate and accommodating and really wanted to take time to listen and help me